BLACKROCK SCI & TECH TRM TR (BSTZ) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:BSTZ - US09260K1016
22.93 USD
+0.21 (+0.92%)
BSTZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. BSTZ has a bad profitability rating. Also its financial health evaluation is rather negative. BSTZ has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
BSTZ had positive earnings in the past year.
BSTZ had a positive operating cash flow in the past year.
BSTZ had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BSTZ had a positive operating cash flow.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.03% | ||
| ROE | 9.39% | ||
| ROIC | 11.26% |
ROA(3y)-17.73%
ROA(5y)0.59%
ROE(3y)-17.95%
ROE(5y)0.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of BSTZ has grown nicely.
BSTZ's Operating Margin has declined in the last couple of years.
BSTZ's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 91.06% | ||
| PM (TTM) | 58.54% | ||
| GM | 91.69% |
OM growth 3Y0.3%
OM growth 5Y-8.94%
PM growth 3Y20.98%
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y-8.53%
2. Health
2.1 Basic Checks
BSTZ has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BSTZ has less shares outstanding
The debt/assets ratio for BSTZ is higher compared to a year ago.
2.2 Solvency
BSTZ has an Altman-Z score of 16.57. This indicates that BSTZ is financially healthy and has little risk of bankruptcy at the moment.
BSTZ has a debt to FCF ratio of 0.08. This is a very positive value and a sign of high solvency as it would only need 0.08 years to pay back of all of its debts.
A Debt/Equity ratio of 0.02 indicates that BSTZ is not too dependend on debt financing.
Although BSTZ does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.08 | ||
| Altman-Z | 16.57 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 0.26 indicates that BSTZ may have some problems paying its short term obligations.
A Quick Ratio of 0.26 indicates that BSTZ may have some problems paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.26 | ||
| Quick Ratio | 0.26 |
3. Growth
3.1 Past
The earnings per share for BSTZ have decreased strongly by -25.36% in the last year.
Measured over the past years, BSTZ shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.63% on average per year.
The Revenue has grown by 148.16% in the past year. This is a very strong growth!
Measured over the past years, BSTZ shows a very negative growth in Revenue. The Revenue has been decreasing by -14.19% on average per year.
EPS 1Y (TTM)-25.36%
EPS 3Y6.9%
EPS 5Y21.63%
EPS Q2Q%-81.13%
Revenue 1Y (TTM)148.16%
Revenue growth 3Y-14.19%
Revenue growth 5YN/A
Sales Q2Q%57.69%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.97 indicates a reasonable valuation of BSTZ.
When comparing the Price/Earnings ratio of BSTZ to the average of the S&P500 Index (26.39), we can say BSTZ is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.97 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.58 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.51
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
BSTZ has a Yearly Dividend Yield of 11.18%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 1.87, BSTZ pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.18% |
5.2 History
BSTZ has been paying a dividend for over 5 years, so it has already some track record.
BSTZ has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
132.64% of the earnings are spent on dividend by BSTZ. This is not a sustainable payout ratio.
DP132.64%
EPS Next 2YN/A
EPS Next 3YN/A
NYSE:BSTZ (12/22/2025, 12:22:56 PM)
22.93
+0.21 (+0.92%)
Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)
Earnings (Next)
Inst Owners27.53%
Inst Owner Change-7.93%
Ins Owners0.17%
Ins Owner Change0%
Market Cap1.58B
Revenue(TTM)246.00M
Net Income(TTM)144.00M
Analysts0
Price TargetN/A
Short Float %0.31%
Short Ratio1.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.18% |
Yearly Dividend2.05
Dividend Growth(5Y)N/A
DP132.64%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.97 | ||
| Fwd PE | N/A | ||
| P/S | 6.41 | ||
| P/FCF | 4.58 | ||
| P/OCF | 4.58 | ||
| P/B | 1.03 | ||
| P/tB | 1.03 | ||
| EV/EBITDA | N/A |
EPS(TTM)2.09
EY9.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)5
FCFY21.82%
OCF(TTM)5
OCFY21.82%
SpS3.58
BVpS22.3
TBVpS22.3
PEG (NY)N/A
PEG (5Y)0.51
Graham Number32.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.03% | ||
| ROE | 9.39% | ||
| ROCE | 14.25% | ||
| ROIC | 11.26% | ||
| ROICexc | 11.26% | ||
| ROICexgc | 11.26% | ||
| OM | 91.06% | ||
| PM (TTM) | 58.54% | ||
| GM | 91.69% | ||
| FCFM | 139.84% |
ROA(3y)-17.73%
ROA(5y)0.59%
ROE(3y)-17.95%
ROE(5y)0.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y4.88%
ROICexgc growth 5YN/A
ROICexc growth 3Y4.97%
ROICexc growth 5YN/A
OM growth 3Y0.3%
OM growth 5Y-8.94%
PM growth 3Y20.98%
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y-8.53%
F-Score6
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.08 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 22400 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 238.89% | ||
| Current Ratio | 0.26 | ||
| Quick Ratio | 0.26 | ||
| Altman-Z | 16.57 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.36%
EPS 3Y6.9%
EPS 5Y21.63%
EPS Q2Q%-81.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)148.16%
Revenue growth 3Y-14.19%
Revenue growth 5YN/A
Sales Q2Q%57.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y194.75%
EBIT growth 3Y-13.93%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.32%
FCF growth 3Y2.74%
FCF growth 5YN/A
OCF growth 1Y76.32%
OCF growth 3Y2.74%
OCF growth 5YN/A
BLACKROCK SCI & TECH TRM TR / BSTZ FAQ
What does BLACKROCK SCI & TECH TRM TR do?
BlackRock Science and Technology Term Trust is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2019-06-26. BlackRock Science and Technology Term Trust (the Trust) is a closed-end management investment company. The Trust's investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by the United States and non-United States science and technology companies in any market capitalization range, selected for their rapid and sustainable growth potential from the development, advancement and use of science and/or technology. The Trust focuses on sectors, such as semiconductors and semiconductor equipment, software, electronic equipment, instruments and components, entertainment, financial services, automobiles, professional services, diversified consumer services, media and others. BlackRock Advisors, LLC is the Trust’s investment adviser.
Can you provide the latest stock price for BLACKROCK SCI & TECH TRM TR?
The current stock price of BSTZ is 22.93 USD. The price increased by 0.92% in the last trading session.
What is the ChartMill technical and fundamental rating of BSTZ stock?
BSTZ has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.